Dr. Laura Shawver Featured on The Burrill Report Podcast
Matching the right drug to a particular patient's tumor type, though increasingly common in treating certain types of cancer, is not yet the norm for ovarian cancer patients. The Clearity Foundation is trying to change that by providing ovarian cancer patients molecular profiling of their tumors so their physicians can make more informed treatment decisions.
We spoke to Laura Shawver, founder of the organization, about her work, her own experience with the disease, and how the foundation is using personalized medicine to change the way physicians treat patients with ovarian cancer. Click The Burrill Report (September 9, 2013): Bringing Personalized Medicine to Ovarian Cancer (.MP3,19.72 Mb) to listen to the podcast
Comments
-
Wow!
Thanks, Alexandra! Nothing like a doctor having walked in your shoes.
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.2K Cancer specific
- 2.8K Anal Cancer
- 440 Bladder Cancer
- 306 Bone Cancers
- 1.6K Brain Cancer
- 28.4K Breast Cancer
- 391 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 12.9K Head and Neck Cancer
- 6.3K Kidney Cancer
- 666 Leukemia
- 789 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 235 Multiple Myeloma
- 7.1K Ovarian Cancer
- 53 Pancreatic Cancer
- 486 Peritoneal Cancer
- 5.3K Prostate Cancer
- 1.2K Rare and Other Cancers
- 532 Sarcoma
- 717 Skin Cancer
- 647 Stomach Cancer
- 190 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards